The trademark application REPEVAX was filed by Sanofi Pasteur Europe, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on September 10, 2018, and it was registered by office on December 18, 2018 without any oppositions.
The application was filed in French (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 1, 2022.
The application claimed as seniority of the French Republic trademark 99818535 registered on October 13, 1999 and filed on October 13, 1999 which was accepted by the office.